Description
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities. Case Number: 857890-39-2
-
Call Us
Land: 0123420191 | Mobile: 072 643 8207
-
Email Us
info@biotechhubafrica.co.za
